Amedeo Smart

Free Medical Literature Service



Gastric Cancer

  Free Subscription

Articles published in
J Clin Oncol
    August 2022
  1. MARON SB, Moya S, Morano F, Emmett MJ, et al
    Epidermal Growth Factor Receptor Inhibition in Epidermal Growth Factor Receptor-Amplified Gastroesophageal Cancer: Retrospective Global Experience.
    J Clin Oncol. 2022;40:2458-2467.
    >> Share

    June 2022
  2. GWEE YX, Chia DKA, So J, Ceelen W, et al
    Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis.
    J Clin Oncol. 2022 Jun 1:JCO2102745. doi: 10.1200/JCO.21.02745.
    >> Share

    March 2022
  3. KIM YW, Min JS, Yoon HM, An JY, et al
    Laparoscopic Sentinel Node Navigation Surgery for Stomach Preservation in Patients With Early Gastric Cancer: A Randomized Clinical Trial.
    J Clin Oncol. 2022 Mar 24:JCO2102242. doi: 10.1200/JCO.21.02242.
    >> Share

    February 2022
  4. ZHAO JJ, Yap DWT, Chan YH, Tan BKJ, et al
    Low Programmed Death-Ligand 1-Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal Adenocarcinoma.
    J Clin Oncol. 2022;40:392-402.
    >> Share

    September 2021
  5. MO DC, Qin L, Ye LJ
    Neoadjuvant Docetaxel, Oxaliplatin, and S-1 in Resectable Advanced Gastric Cancer.
    J Clin Oncol. 2021 Sep 30:JCO2101528. doi: 10.1200/JCO.21.01528.
    >> Share

  6. KANG YK, Yook JH, Park YK, Lee JS, et al
    PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer.
    J Clin Oncol. 2021;39:2903-2913.
    >> Share

    August 2021
  7. TEH SH, Uong S, Lin TY, Shiraga S, et al
    Clinical Outcomes Following Regionalization of Gastric Cancer Care in a US Integrated Health Care System.
    J Clin Oncol. 2021 Aug 2:JCO2100480. doi: 10.1200/JCO.21.00480.
    >> Share

    March 2021
  8. HAFFNER I, Schierle K, Raimundez E, Geier B, et al
    HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study.
    J Clin Oncol. 2021 Mar 25:JCO2002761. doi: 10.1200/JCO.20.02761.
    >> Share

  9. VAN DER VEEN A, Brenkman HJF, Seesing MFJ, Haverkamp L, et al
    Laparoscopic Versus Open Gastrectomy for Gastric Cancer (LOGICA): A Multicenter Randomized Clinical Trial.
    J Clin Oncol. 2021;39:978-989.
    >> Share

  10. SHAH MA, Bodoky G, Starodub A, Cunningham D, et al
    Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1).
    J Clin Oncol. 2021;39:990-1000.
    >> Share

    January 2021
  11. LU Z, Fang Y, Liu C, Zhang X, et al
    Early Interdisciplinary Supportive Care in Patients With Previously Untreated Metastatic Esophagogastric Cancer: A Phase III Randomized Controlled Trial.
    J Clin Oncol. 2021 Jan 8:JCO2001254. doi: 10.1200/JCO.20.01254.
    >> Share

    November 2020
  12. MOEHLER M, Dvorkin M, Boku N, Ozguroglu M, et al
    Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100.
    J Clin Oncol. 2020 Nov 16:JCO2000892. doi: 10.1200/JCO.20.00892.
    >> Share

    August 2020
  13. HYUNG WJ, Yang HK, Park YK, Lee HJ, et al
    Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial.
    J Clin Oncol. 2020 Aug 20:JCO2001210. doi: 10.1200/JCO.20.01210.
    >> Share

    July 2020
  14. CATENACCI DVT, Rasco D, Lee J, Rha SY, et al
    Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma.
    J Clin Oncol. 2020;38:2418-2426.
    >> Share

    June 2020
  15. MAKIYAMA A, Sukawa Y, Kashiwada T, Kawada J, et al
    Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study).
    J Clin Oncol. 2020;38:1919-1927.
    >> Share

    April 2020
  16. FUKUOKA S, Hara H, Takahashi N, Kojima T, et al
    Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603).
    J Clin Oncol. 2020 Apr 28:JCO1903296. doi: 10.1200/JCO.19.03296.
    >> Share

    February 2020
  17. IQBAL S, McDonough S, Lenz HJ, Ilson D, et al
    Randomized, Phase II Study Prospectively Evaluating Treatment of Metastatic Esophageal, Gastric, or Gastroesophageal Cancer by Gene Expression of ERCC1: SWOG S1201.
    J Clin Oncol. 2020;38:472-479.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016